Rituximab-mediated complement-dependent cytotoxicity enhanced by gemcitabine in older patients with previously rituximab-treated diffuse large B-cell lymphoma: Study protocol

Satoshi Yamasaki, Akiko Kada, Hirokazu Nagai, Isao Yoshida, Ilseung Choi, Yasuhiko Miyata, Yuri Miyazawa, Akiko Saito, Hiromi Iwasaki

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Rituximab-mediated complement-dependent cytotoxicity enhanced by gemcitabine in older patients with previously rituximab-treated diffuse large B-cell lymphoma: Study protocol'. Together they form a unique fingerprint.

Medicine & Life Sciences